Bone Therapeutics: H1 newsflow delivered on time is a good sign when we look towards H2

BUY, Fair Value EUR26 (+37%)
News published on September Wednesday 23, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities